Back to Search
ROBERT MENNEL, MD
MD
Medical Oncology Physician
NPI: 1265475677IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
F6039(TX)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1970
Research & Publications (17)
Robert Gary Mennel, MD: a conversation with the editor.
PMID 17106500·Proc (Bayl Univ Med Cent)·2006
8-other
Primary effusion lymphoma diagnosed by pericardiocentesis.
PMID 19169406·Proc (Bayl Univ Med Cent)·2009
8-other
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
The ectopic adrenocorticotropic hormone syndrome in carcinoid tumors.
PMID 18382753·Proc (Bayl Univ Med Cent)·2008
8-other
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
PMID 17954709·J Clin Oncol·2007
6-review
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.
PMID 16110015·J Clin Oncol·2005
3-trial
Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors.
PMID 16377585·Cancer Invest·2005
3-trial
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
PMID 16001992·Clin Breast Cancer·2005
3-trial
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
PMID 15459210·J Clin Oncol·2004
3-trial
Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer.
PMID 12123539·Clin Breast Cancer·2002
3-trial
Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.
PMID 11899353·Clin Breast Cancer·2001
8-other
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
PMID 11251019·J Clin Oncol·2001
6-review
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study.
PMID 11970744·Clin Breast Cancer·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3410 WORTH ST
DALLAS, TX 75246 - Phone
- (214) 370-1000
Quick Facts
- NPI
- 1265475677
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 56
- Publications
- 17
Are you this provider?
Claim Your Profile